A private supply portal for compounding pharmacies, clinical research programs, and qualified bulk buyers. Every lot, every batch, documented.
A credentialed supply portal for compounding pharmacies, IRB-approved research programs, and qualified bulk buyers. Research Use Only.
From GLP-1s and metabolic agents, to recovery and tissue-repair peptides, to GH-secretagogues and specialty peptides. A constantly growing catalogue of the top peptides on the market. Three pricing tiers. Every vial ships with batch-specific COA.
Browse catalogueMulti-gram active pharmaceutical ingredients with full DMF documentation where filed, transparent per-SKU 503A status disclosure, and direct supplier facility audits. Quoted by RFQ.
Bulk catalogue & RFQLong-term supply agreements for IRB-approved research programs and licensed compounding pharmacies. Custom blends, dedicated batch reservation, and white-glove logistics.
Apply for partnershipHover any test to see exactly what it certifies and the acceptable range. Specifications follow ICH Q3 and USP <1226> guidance. The COA travels with every batch.
Reverse-phase HPLC quantifies the target peptide as a fraction of total UV-active material. The single most important purity readout.
Validated cGMP suppliers across China and the wider Asia bench, tied together by on-the-ground audits and the Youth Consulting partnership. Multi-source by design: redundancy on every SKU, first access to new compounds, suppliers competing for our orders.
Every priority SKU is dual-sourced. A stockout at one supplier never becomes a stockout for our partners. Orders reroute to the validated backup with the same COA package, same purity spec, same lead time.
Suppliers compete for our orders, every cycle. We benchmark twice a year and pass the floor through to partners as volume-tier contract pricing. The network does the negotiating so you don't have to.
A wide bench means we see new compounds as they're released: Phase-2 readouts, off-label novelties, fresh GLP-1 analogs. The catalogue refreshes bi-weekly because of it, and partners get first access ahead of the broader market.
Through Youth Consulting we sit in the loop with nearly every new peptide-synthesis lab opening in China. A constant inbound stream of higher-quality candidates that keeps our existing roster competing for shelf space, and gives us a credible threat of replacement at every benchmark cycle.